Organization
Stanford University School of Medicine, Stanford, United States of America
1 abstract
Abstract
BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN SUBJECTS WITH ILD IN A PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF MT-7117 IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSISOrg: University of Michigan, Ann Arbor, United States of America, Hospital Universitario 12 de Octubre, Madrid, Spain, Stanford University School of Medicine, Stanford, United States of America, University College London and Royal Free Hospital, London, United Kingdom, IRCCS San Raffaele University Hospital, Milan, Italy,